New Female Viagra - no....

There has been a lot of publicity about the new drug which purportedly increases the sex drive in women.

Unfortunately the hype is much more significant that the actual results.

Flibanserin (to be marketed as Addyi) is a drug related to the SSRI antidepressants.

Previously the FDA advisory committee twice declined to recommend the drug because the treatment effect was not much larger than placebo. In three new studies, flibanserin was associated with an increase of 0.5–1 satisfying sexual events per month — up from a baseline of 2–3 per month — compared with placebo. That's roughly a 10% greater treatment effect over placebo.

One panel member said following the vote: "The benefits are modest, maybe less than modest, which puts it in good company with other approved drugs, unfortunately."

So for women with lowered sex drive this may become an expensive waste of time. Unlike Viagra like medications, which actually improve male performance, this drug may only increased the sex drive; and then minimally.

Expect and expensive and likely successful advertising campaign once the FDA approves it.